Table 3.

Clinical characteristics between patients who respond to only CLZ (CLZ-TRS) and those requiring augmentation strategies (CLZ-UTRS).

Variables	CLZ Only (CLZ-TRS) n = 49 Mean (S.D)	CLZ + Augmentation Strategies (CLZ-UTRS) n = 51 Mean (S.D)	p Value
CLZ dose (mg/day)	306.75 (167.87)	365.13 (135.16)	0.033 *
CLZ plasma levels (ng/mL)	354.6 (187.01)	476.6 (169.14)	<0.001 **
NCLZ plasma levels (ng/mL)	217.0 (118.07)	284.9 (79.21)	<0.001 **
Wellbeing (SWEMWBS) score	25.21 (4.90)	22.62 (4.07)	0.003 *
Genal functioning (GAF) score	74.46 (13.14)	71.96 (9.76)	0.141
PANSS-positive	11.58 (3.96)	14.93 (4.42)	<0.001 **
BNSS overall score	20.62 (15.54)	25.39 (15.09)	0.072
BNSS Motivation and Pleasure Factor	13.47 (9.10)	15.42 (9.44)	0.160
BNSS Expression factor	7.15 (7.48)	9.98 (7.38)	0.037 *

* p < 0.05. ** p < 0.001.